Establishment of a Predictive In Vitro Assay for Assessment of the Hepatotoxic Potential of Oligonucleotide Drugs
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Establishment of a Predictive In Vitro Assay for Assessment of the Hepatotoxic Potential of Oligonucleotide Drugs
Authors
Keywords
Hepatocytes, Toxicity, Oligonucleotides, Albumins, Secretion, Cytokines, Rodents, Apoptosis
Journal
PLoS One
Volume 11, Issue 7, Pages e0159431
Publisher
Public Library of Science (PLoS)
Online
2016-07-22
DOI
10.1371/journal.pone.0159431
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development of a Method for Profiling Protein Interactions with LNA-Modified Antisense Oligonucleotides Using Protein Microarrays
- (2016) Satoko Kakiuchi-Kiyota et al. Nucleic Acid Therapeutics
- Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides
- (2015) Richard S. Geary et al. ADVANCED DRUG DELIVERY REVIEWS
- A snapshot of biologic drug development
- (2015) L Andrews et al. HUMAN & EXPERIMENTAL TOXICOLOGY
- In silicoandin vitroevaluation of exonic and intronic off-target effects form a critical element of therapeutic ASO gapmer optimization
- (2015) Piotr J. Kamola et al. NUCLEIC ACIDS RESEARCH
- Sequence motifs associated with hepatotoxicity of locked nucleic acid—modified antisense oligonucleotides
- (2014) Andrew D. Burdick et al. NUCLEIC ACIDS RESEARCH
- Antisense Oligonucleotide Therapies
- (2014) Kendall S. Frazier TOXICOLOGIC PATHOLOGY
- Cellular Uptake and Intracellular Trafficking of Oligonucleotides: Implications for Oligonucleotide Pharmacology
- (2014) R.L. Juliano et al. Nucleic Acid Therapeutics
- A Phase I Study of EZN-3042, a Novel Survivin Messenger Ribonucleic Acid (mRNA) Antagonist, Administered in Combination With Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
- (2013) Elizabeth A. Raetz et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Hepatotoxic Potential of Therapeutic Oligonucleotides Can Be Predicted from Their Sequence and Modification Pattern
- (2013) Peter H. Hagedorn et al. Nucleic Acid Therapeutics
- Abstract A216: Results of a phase 1, open-label, dose-escalation study evaluating the safety and tolerability of EZN-3042, a survivin mRNA antagonist, administered with docetaxel (D) in adult patients (Pts) with advanced solid tumors.
- (2012) A. W. Tolcher et al. MOLECULAR CANCER THERAPEUTICS
- Mechanisms of single-stranded phosphorothioate modified antisense oligonucleotide accumulation in hepatocytes
- (2011) Erich Koller et al. NUCLEIC ACIDS RESEARCH
- Short locked nucleic acid antisense oligonucleotides potently reduce apolipoprotein B mRNA and serum cholesterol in mice and non-human primates
- (2010) Ellen Marie Straarup et al. NUCLEIC ACIDS RESEARCH
- Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents
- (2009) C. A. Stein et al. NUCLEIC ACIDS RESEARCH
- Circulating microRNAs, potential biomarkers for drug-induced liver injury
- (2009) K. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now